Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Atul Dandekar currently holds 14,143 shares of Maze Therapeutics, Inc. (MAZE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Atul Dandekar has been a net seller of MAZE stock. They have purchased $0 and sold $3.1M worth of shares.
Atul Dandekar's most recent insider trade was on Aug 28, 2026, when they sold 7,500 shares at $0.00 per share.
Atul Dandekar serves as Executive at Maze Therapeutics, Inc. (MAZE). They have executed 8 insider transactions totaling $3.1M over their tenure at the company.
Atul Dandekar holds the position of Executive at Maze Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Atul Dandekar has shown a selling trading pattern, with $0 in total purchases and $3.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Atul Dandekar was on Dec 29, 2025, when they sold $2.7M worth of MAZE shares. This transaction involved 66,365 shares at $40.51 per share.
Atul Dandekar currently owns 14,143 shares of Maze Therapeutics, Inc. (MAZE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Atul Dandekar's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Atul Dandekar has 8 Form 4 filings on record as an insider at Maze Therapeutics, Inc..
Set alerts for Atul Dandekar and 40,000+ other insiders.